Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · IEX Real-Time Price · USD
2.020
+0.020 (1.00%)
At close: Jul 19, 2024, 4:00 PM
1.980
-0.040 (-1.98%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $137.37 million as of July 22, 2024. Its market cap has decreased by -90.06% in one year.
Market Cap
137.37M
Enterprise Value
-232.95M
1-Year Change
-90.06%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $137.37M, a decrease of -87.15%. That is a compound annual growth rate of -55.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 137.40M | -86.18% |
| Dec 29, 2023 | 993.90M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.98% |
| Jan 7, 2022 | 1.07B | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 141.95M |
| EUDA Health Holdings | 140.51M |
| Vigil Neuroscience | 139.81M |
| DiaMedica Therapeutics | 138.91M |
| Cellectis | 138.44M |
| Invivyd | 137.21M |
| Corvus Pharmaceuticals | 136.36M |
| Electromed | 136.24M |